Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OcluMed is a healthcare company focused on the development and commercialization of advanced nutritional eye drops designed to support ocular health and clarity. The company's flagship product, OcluMed, utilizes a patented formulation of antioxidants and nutrients, including N-acetylcarnosine and L-carnosine, to address age-related eye conditions such as cataracts and macular degeneration. By targeting the oxidative stress and protein glycation that contribute to lens clouding, OcluMed provides a non-invasive alternative or adjunct to traditional surgical interventions. The company serves both the human and veterinary markets, offering specialized formulations for pets as well.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OcluMed.